Cell-mediated autoimmune diseases of the skin: Some hypotheses

Medical Hypotheses

Volumn 49, Issue 3, 1997, Pages 241-245

  Morhenn, V B ^a  

^a California Skin Research Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALOPECIA AREATA; ARTICLE; AUTOIMMUNITY; CELL MEDIATED CYTOTOXICITY; DISEASE SEVERITY; GRANULOMA ANNULARE; KERATINOCYTE; LICHEN PLANUS; PRIORITY JOURNAL; PSORIASIS; SARCOIDOSIS; SKIN DISEASE; T LYMPHOCYTE; THYMUS; VITILIGO;

EID: 0030614312     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-9877(97)90209-7     Document Type: Article

References (35)

1. +) in both normal and diseased human skin. Arch Dermatol Res 1989; 281: 24-30.
2. De Panfilis G. [Analogies between the thymus and epidermis]. G Ital Dermato Venereol 1990; 125: 479-486.
3. Katz S I, Tamaki K, Sachs D. Epidermal Langerhans cells are derived from and are repopulated by mobile precursor cells which originate in bone marrow. Nature 1979; 282: 324-326.
4. Morhenn V B, Lee, S W, Ilnicka M et al. Activated human Langerhans cells express mRNA for interleukin-1γ and interleukin-1β and produce these cytokines but do not secrete them. Cytokine 1992; 4: 500-505.
5. Kupper T S, Chua A B, Flood P et al. Interleukin 1 gene expression in cultured human keratinocytes is augmented by ultraviolet irradiation. J Clin Invest 1987; 80: 430-436.
6. Larrick J W, Morhenn, V B, Chiang Y L et al. Activated Langerhans cells release tumor necrosis factor. J Leuk Biol 1989; 45: 429-433.
7. Sieling P A, Chatterjee D, Porcelli S A et al. CD1-restricted T cell recognition of microbial lipoglycan antigens. Science 1995; 269: 227-230.
8. Castaño A R, Tangri S, Miller J E W et al. Peptide binding and presentation by mouse CD1. Science 1995; 269: 223-226.
9. Iwabuchi K, Nakayama I, McCoy R L et al. Cellular and peptide requirements for in vitro clonal deletions of immature thymocytes. Proc Natl Acad Sci USA 1992; 89: 9000-9004.
10. Grabbe S, Gallo R L, Lindgren A et al. Deficient antigen presentation by Langerhans cells from athymic (nu/nu) mice. J Immunol 1993: 3430-3439.
11. Bonomo A, Matzinger P. Thymus epithelium induces tissue-specific tolerance. J Exp Med 1993; 177: 1153-1164.
12. Speiser D E, Pircher H P, Ohashi P S et al. Clonal deletion induced by either radioresistant thymic host cells or lymphohemopoietic donor cells at different stages of class I-restricted T cell ontogeny. J Exp Med 1992; 175: 1277-1283.
13. James D G. Sarcoidosis of the skin. In: Fitzpatrick T B, Eisen A Z, Wolff K, Freedberg I M, Austin K F, eds. Dermatology in General Medicine, 3rd edn. New York: McGraw-Hill, 1987: 1888-1899.
14. Wucherpfennig K W, Strominger J L. Molecular mimicry in T cell-mediated autoimmunity: viral peptides activate human T cell clones specific for myelin basic protein. Cell 1995; 80: 695-705.
15. Steinman L. Multiple sclerosis: A coordinated immunologic attack against myelin in the central nervous system. Cell 1996; 85: 229-302.
16. Valdimarsson H, Baker B S, Jonsdottir I et al. Psoriasis: a T-cell mediated autoimmune disease induced by streptococcal superantigens. Immunol Today 1995; 16: 145-149.
17. Beare J M. Granuloma annulare. In: Rook A, Wilkinson D S eds. Textbook of Dermatology, 2nd edn. Oxford: Blackwell Scientific, 1959: 1213-1216.
18. Dahl M, Goltz R W. Granuloma annulare. In: Fitzpatrick T B, Eisen A Z, Wolff K, Freedberg I M, Austin K F, eds. Dermatology in General Medicine, 3rd edn. New York: McGraw-Hill, 1987: 1018-1023.
19. Todes-Taylor N, Turner R, Wood G S et al. T cell subpopulations in alopecia areata. J Am Acad Dermatol 1984; 11: 216-224.
20. Colombe B W, Price V H, Khoury E et al. HLA class II antigen associations help to define two types of alopecia areata. J Am Acad Dermatol 1995; 33: 757-764.
21. Isaac M, McNeely M C. Dermatitis herpetiformis associated with lichen planopilaris. J Am Acad Dermatol 1995; 33: 1050-1051.
22. Boehncke W-H, Dressel D, Zollner T M. Pulling the trigger on psoriasis. Nature 1996; 379: 777.
23. Morhenn V B. The etiology of lichen planus: an hypothesis. Am J Dermatopathol 1986; 8: 154-157.
24. Arndt K. Disorders of the dermal-epidermal interface and the dermis. In: Fitzpatrick T B, Eisen A Z, Wolff K, Freedberg I M, Austin K F, eds. Dermatology in General Medicine, 3rd edn. New York: McGraw-Hill, 1987: 967-972.
25. Samman P D. Lichen planus and lichenoid eruptions. In: Rook A, Wilkinson D S. Textbook of Dermatology, 2nd edn. Oxford: Blackwell Scientific, 1969: 1202.
26. Bendelac A. CD1: Presenting unusual antigens to unusual T lymphocytes. Science 1995; 269: 185-186.
27. Cunliffe W H, Hall R, Stevenson C J et al. Alopecia areata, thyroid disease, and autoimmunity. Br J Dermatol 1969; 81: 877.
28. Duvick M, Hordinsky M K, Fiedler V C et al. HLA-D locus associations in alopecia areata. Arch Dermatol 1991; 127: 64-68.
29. Tobin D J, Orentreich N, Fenton D A et al. Antibodies to hair follicles in alopecia areata. J Invest Dermatol 1994; 102: 721-724.
30. Mosher D B, Fitzpatrick T B, Ortonne J-P, Hori Y. Disorders of pigmentation. In: Fitzpatrick T B, Eisen A Z, Wolff K, Freedberg I M, Austin K F, eds. Dermatology in General Medicine, 3rd edn. New York: McGraw-Hill, 1987: 813-814.
31. Kalz F, Schopflocher P. Vitiligo and lymphocytes. Hautarzt 1965; 16: 105-108.
32. Carroll J M, Romero M R, Watt F M. Suprabasal integrin expression in the epidermis of transgenic mice results in developmental defects and a phenotype resembling psoriasis. Cell 1995; 83: 957-968.
33. Gottlieb S L, Gilleaudeau P, Johnson R et al. Response of psoriasis to a lymphocyte-selective toxin (DAB389IL-2) suggests a primary immune, but not keratinocyte, pathogenic basis. Nature Med 1995; 1: 442-447.
34. Hartle M D, Kubler M D, Leigh I M et al. Aberrant integrin expression during epidermal wound healing and in psoriatic epidermis. J Clin Invest 1992; 89: 1892-1901.
35. Mansbridge J N, Morhenn V B. The cell membrane in psoriasis. In: Roenigk H H, Maibach H I, eds. Psoriasis. Basel: S Karger, 1996, in press.